Physician profile
Dirk Steinert
NPI 1033137294
$12,094.29
in general payments reported to CMS, 2019-2025
9 companies · $2,960 in 2025
The $2,960 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $14.16 · 2021: $1,810 · 2022: $3,365 · 2023: $1,456 · 2024: $2,291 · 2025: $2,960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,265 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,250 · Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,265.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,250.00 |
| Food and Beverage | $191.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $8,229.46 | 2021-2025 | |
| Glaxosmithkline, LLC. | $1,750.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,319.16 | 2020-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $272.34 | 2021-2022 | |
| Novo Nordisk INC | $219.84 | 2019-2024 | |
| Medtronic, INC. | $152.82 | 2022 | |
| Alexion Pharmaceuticals, INC. | $125.00 | 2023 | Strensiq |
| Abbott Laboratories | $25.67 | 2023 | Freestyle Libre 3 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dirk Steinert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.